MENU
PTH
ETF ticker: NASDAQ
PRICE
CHANGE
NET ASSETS

PTH stock forecast, quote, news & analysis

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index")... Show more

Category: #Health
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
a Summary for PTH with price predictions
Nov 11, 2026

PTH's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PTH turned positive on November 10, 2026. Looking at past instances where PTH's MACD turned positive, the stock continued to rise in 41 of 46 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 55 of 64 cases where PTH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +6.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where PTH advanced for three days, in 274 of 324 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PTH as a result. In 78 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 82%.

PTH moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

PTH broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for PTH entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Illumina (NASDAQ:ILMN), Guardant Health (NASDAQ:GH), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks to track the investment results (before fees and expenses) of the Dorsey Wright® Healthcare Technical Leaders Index (the "underlying index"). The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or "momentum" characteristics.

Market Cap

The average market capitalization across the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF is 29.38B. The market cap for tickers in the group ranges from 727.85M to 44.78B. NTRA holds the highest valuation in this group at 44.78B. The lowest valued company is CGEM at 727.85M.

High and low price notable news

The average weekly price growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was -1%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 17%. ETON experienced the highest price growth at 35%, while HALO experienced the biggest fall at -22%.

Volume

The average weekly volume growth across all stocks in the Invesco Dorsey Wright Healthcare Momentum ETF (PTH) ETF was -27%. For the same stocks of the ETF, the average monthly volume growth was 31% and the average quarterly volume growth was -26%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 52
Price Growth Rating: 46
SMR Rating: 75
Profit Risk Rating: 67
Seasonality Score: 3 (-100 ... +100)